Phathom Pharmaceuticals, Inc. — Director's Dealing 2026

Jan 27, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2026-01-23

Reporting Person: Parikh Asit (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-23	Common Stock	G	80500	—	Disposed	50500	Direct
2026-01-23	Common Stock	G	80500	—	Acquired	80500	Indirect

Footnotes

F1: Reflects shares transferred for no consideration to a trust for the benefit of the Reporting Person's spouse and for which the Reporting Person serves as trustee.

F2: The shares are subject to a lock-up agreement entered into by the Reporting Person in connection with the underwriting agreement dated January 7, 2026 (the Lock-Up Agreement). The trust has agreed in writing to be bound by the same terms described in the Lock-Up Agreement to the extent and for the duration that such terms remain in effect at the time of the transfer.